即將上市(暗盤(pán)交易時(shí)段:今日16:15-18:30)
| 公司名稱(chēng)▼
/
代號(hào)▼ | 行業(yè) | 招股價(jià) | 每手股數(shù) | 入場(chǎng)費(fèi) | 招股截止日 | 暗盤(pán)日期▼ | 上市日期▲ |
|
公司名稱(chēng)/代號(hào) | 現(xiàn)價(jià)2 | 今日升跌▼ | 十天升跌▼ | 市值▼ | 市盈率 (倍)▼ | 市帳率 (倍)▼ | 派息比率 (%)▼ | 股東權(quán)益 回報(bào)率(%)▼ | 經(jīng)營(yíng) 利潤(rùn)率(%)▼ | 總債項(xiàng)/ 股東權(quán)益(%)▼ | 選擇比較 |
荃信生物-B 02509.HK | 14.980 | +1.216% | +33.51% | 33.27億 | N/A | 13.66 | N/A | -14,655.00% | -20,553.00% | 23,041.00% | |
信達(dá)生物 01801.HK | 77.850 | +6.425% | +37.67% | 1,285.76億 | N/A | 9.14 | N/A | -72.00% | 32.00% | 2,158.00% | |
中國(guó)生物製藥 01177.HK | 4.690 | +3.077% | +15.52% | 879.88億 | 23.05 | 2.59 | 34.398% | 1,095.00% | 2,562.00% | 3,038.00% | |
康方生物 09926.HK | 85.650 | +4.134% | +5.22% | 768.79億 | N/A | 10.61 | N/A | -755.00% | -1,715.00% | 5,800.00% | |
科倫博泰生物-B 06990.HK | 350.800 | +3.664% | +11.15% | 550.24億 | N/A | 22.66 | N/A | -806.00% | -718.00% | 383.00% | |
三生製藥 01530.HK | 21.700 | +7.426% | +15.06% | 520.67億 | 23.66 | 3.17 | 27.254% | 1,354.00% | 2,811.00% | 2,303.00% | |
藥明合聯(lián) 02268.HK | 42.150 | +1.079% | +17.74% | 507.01億 | 44.41 | 7.16 | N/A | 1,611.00% | 3,018.00% | 748.00% | |
諾誠(chéng)健華 09969.HK | 13.200 | +12.054% | +27.66% | 232.44億 | N/A | 3.25 | N/A | -655.00% | -4,097.00% | 1,891.00% | |
和黃醫(yī)藥 00013.HK | 25.100 | +4.149% | +22.14% | 218.77億 | 73.31 | 3.71 | N/A | 496.00% | 28.00% | 1,182.00% | |
映恩生物-B 09606.HK | 238.400 | +11.194% | +19.98% | 209.88億 | N/A | N/A | N/A | -5,195.00% | -5,225.00% | N/A | |
綠葉製藥 02186.HK | 3.250 | +10.544% | +51.87% | 122.25億 | 24.36 | 0.81 | N/A | 333.00% | 2,313.00% | 7,292.00% | |
同源康醫(yī)藥-B 02410.HK | 24.200 | +2.110% | +7.56% | 88.63億 | N/A | 17.99 | N/A | -8,249.00% | -35,057,103.00% | 3,770.00% | |
MIRXES-B 02629.HK | 29.150 | -1.520% | 0.00% | 80.55億 | N/A | N/A | N/A | -4,427.00% | -39,819.00% | N/A | |
復(fù)宏漢霖 02696.HK | 48.200 | +5.702% | +14.49% | 78.77億 | 30.02 | 8.17 | N/A | 2,723.00% | 1,692.00% | 12,106.00% | |
康寧傑瑞製藥-B 09966.HK | 8.130 | +2.008% | -6.01% | 78.23億 | 44.23 | 4.01 | N/A | 908.00% | 2,754.00% | 1,015.00% | |
博安生物 06955.HK | 11.800 | +6.306% | +21.90% | 63.24億 | 81.27 | 3.62 | N/A | 445.00% | 1,457.00% | 4,170.00% | |
宜明昂科-B 01541.HK | 14.280 | +1.277% | +44.24% | 56.59億 | N/A | 8.06 | N/A | -4,652.00% | -42,231.00% | 2,009.00% | |
維昇藥業(yè)-B 02561.HK | 47.500 | +3.825% | +3.37% | 54.12億 | N/A | N/A | N/A | -7,553.00% | N/A | 98.00% | |
君實(shí)生物 01877.HK | 22.950 | +7.494% | +44.70% | 50.33億 | N/A | 3.62 | N/A | -2,181.00% | -6,532.00% | 4,986.00% | |
綠竹生物-B 02480.HK | 24.000 | +1.695% | +18.52% | 47.82億 | N/A | 5.31 | N/A | -1,971.00% | N/A | 791.00% | |
派格生物醫(yī)藥-B 02565.HK | 9.570 | -0.520% | N/A | 36.94億 | N/A | N/A | N/A | -14,693.00% | N/A | 3,629.00% | |
|